Recent Finacing
Recent Raise
Developer of a pre-clinical, second-generation COVID-19 vaccine leveraging gene-therapy platforms to advance SARS-CoV-2 prevention.
Recent Investors
Total Raised
Funding round
Investor
See the team members at Coalition for Epidemic Preparedness Innovations.
